SEC Filings
| Filing date | Form | Description | View |
|---|---|---|---|
| 424B5 | Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3 |
View HTML | |
| DEF 14A | Official notification to shareholders of matters to be brought to a vote ("Proxy") |
View HTML | |
| SC 13D | Filing by person(s) reporting owned shares of common stock in a public company >5% |
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML |
Data provided by Kaleidoscope.
For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.
